Boston-based Ginkgo Bioworks, an organism company, has secured $290 million in Series E financing. The investors included T. Rowe Price Associates, Inc.
Source: Press Release
Boston-based Ginkgo Bioworks, an organism company, has secured $290 million in Series E financing. The investors included T. Rowe Price Associates, Inc.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.